Cargando…

Short-term results of the management of severe bone defects in primary TKA with cement and K-wires

OBJECTIVE: The aim of this study was to evaluate the results of cement and kirschner wire augmentation in the management of bone defects in primary TKA. METHODS: Twenty-four patients (10 male, 14 female; mean age: 66 years) with uncontained unilateral medial tibial articular bone defect who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilgen, Muhammet Sadik, Eken, Gokay, Guney, Nejat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Association of Orthopaedics and Traumatology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197322/
https://www.ncbi.nlm.nih.gov/pubmed/28768575
http://dx.doi.org/10.1016/j.aott.2017.02.002
Descripción
Sumario:OBJECTIVE: The aim of this study was to evaluate the results of cement and kirschner wire augmentation in the management of bone defects in primary TKA. METHODS: Twenty-four patients (10 male, 14 female; mean age: 66 years) with uncontained unilateral medial tibial articular bone defect who underwent TKA between 2010 and 2014 were included in this study. The average follow up time was 33.7 months. Patients were divided to two groups according to the size of the bone defect (Group 1: <20 mm, Group 2: >20 mm). The tibial defect was reconstructed by using cement and K-wires. We used posterior stabilized prosthesis with no tibial stem extension. RESULTS: The preoperative and postoperative lower extremity mechanical axis in Group I was in a mean varus of 15° and mean varus of 3°, respectively (p < 0.001). The preoperative and postoperative lower extremity mechanical axis in Group 2 was in a mean varus of 20° and mean varus of 3° respectively in Group II (p < 0.001). None of the patients neither suffered from failure of K-wires nor loosening. CONCLUSION: The use of cement and K-wires augmentation appears to be a simple and cost-effective treatment option for the tibial bone defects in primary TKA. LEVEL OF EVIDENCE: Level IV, Therapeutic study.